Global Clinical Perfusion Service 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI11242982

Publication Date:

November 7, 2024

Pages:

125

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Clinical Perfusion Service refers to the specialized medical service provided by perfusionists, who are trained healthcare professionals responsible for managing the physiological and metabolic needs of patients during surgeries that require cardiopulmonary bypass, such as open-heart surgery. Perfusionists operate complex machinery, like the heart-lung machine, which temporarily takes over the function of the heart and lungs, ensuring that blood and oxygen continue to circulate throughout the body while the surgeon performs the procedure. This service is critical in maintaining patient stability during these highly invasive and delicate surgeries, ensuring that vital organs are protected and supported throughout the operation.
The global Clinical Perfusion Service market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淐linical Perfusion Service Industry Forecast鈥� looks at past sales and reviews total world Clinical Perfusion Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Clinical Perfusion Service sales for 2023 through 2029. With Clinical Perfusion Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Clinical Perfusion Service industry.
This Insight Report provides a comprehensive analysis of the global Clinical Perfusion Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Clinical Perfusion Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Clinical Perfusion Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Clinical Perfusion Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Clinical Perfusion Service.
United States market for Clinical Perfusion Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Clinical Perfusion Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Clinical Perfusion Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Clinical Perfusion Service players cover Perfusion Life, Keystone, Perfusion Solution Inc, EPS, Comprehensive Care Services, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Clinical Perfusion Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Cardiac Perfusion Services
Respiratory Support Perfusion Services
Neurological Perfusion Services
Others
Segmentation by Application:
Cardiac Surgery
Lung Surgery
Organ Transplantation
Extracorporeal Membrane Oxygenation (ECMO)
High-Risk Obstetrics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Cardiac Perfusion Services
Respiratory Support Perfusion Services
Neurological Perfusion Services
Others
Segmentation by Application:
Cardiac Surgery
Lung Surgery
Organ Transplantation
Extracorporeal Membrane Oxygenation (ECMO)
High-Risk Obstetrics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Perfusion Life
Keystone
Perfusion Solution Inc
EPS
Comprehensive Care Services
SpecialtyCare
ECCare
Perfusion Partners
Epic Cardiovascular Services
Procirca
Cambridge Perfusion
Manchester Perfusion Practce
Heartbeat Perfusion Solutions
XVIVO
Life Systems
Adendorff

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Clinical Perfusion Service 麻豆原创 Size 2019-2030
2.1.2 Clinical Perfusion Service 麻豆原创 Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Clinical Perfusion Service by Country/Region, 2019, 2023 & 2030
2.2 Clinical Perfusion Service Segment by Type
2.2.1 Cardiac Perfusion Services
2.2.2 Respiratory Support Perfusion Services
2.2.3 Neurological Perfusion Services
2.2.4 Others
2.3 Clinical Perfusion Service 麻豆原创 Size by Type
2.3.1 Clinical Perfusion Service 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Clinical Perfusion Service 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Clinical Perfusion Service Segment by Application
2.4.1 Cardiac Surgery
2.4.2 Lung Surgery
2.4.3 Organ Transplantation
2.4.4 Extracorporeal Membrane Oxygenation (ECMO)
2.4.5 High-Risk Obstetrics
2.4.6 Others
2.5 Clinical Perfusion Service 麻豆原创 Size by Application
2.5.1 Clinical Perfusion Service 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Clinical Perfusion Service 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Clinical Perfusion Service 麻豆原创 Size by Player
3.1 Clinical Perfusion Service 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Clinical Perfusion Service Revenue by Player (2019-2024)
3.1.2 Global Clinical Perfusion Service Revenue 麻豆原创 Share by Player (2019-2024)
3.2 Global Clinical Perfusion Service Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Clinical Perfusion Service by Region
4.1 Clinical Perfusion Service 麻豆原创 Size by Region (2019-2024)
4.2 Global Clinical Perfusion Service Annual Revenue by Country/Region (2019-2024)
4.3 Americas Clinical Perfusion Service 麻豆原创 Size Growth (2019-2024)
4.4 APAC Clinical Perfusion Service 麻豆原创 Size Growth (2019-2024)
4.5 Europe Clinical Perfusion Service 麻豆原创 Size Growth (2019-2024)
4.6 Middle East & Africa Clinical Perfusion Service 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Clinical Perfusion Service 麻豆原创 Size by Country (2019-2024)
5.2 Americas Clinical Perfusion Service 麻豆原创 Size by Type (2019-2024)
5.3 Americas Clinical Perfusion Service 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Clinical Perfusion Service 麻豆原创 Size by Region (2019-2024)
6.2 APAC Clinical Perfusion Service 麻豆原创 Size by Type (2019-2024)
6.3 APAC Clinical Perfusion Service 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Clinical Perfusion Service 麻豆原创 Size by Country (2019-2024)
7.2 Europe Clinical Perfusion Service 麻豆原创 Size by Type (2019-2024)
7.3 Europe Clinical Perfusion Service 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Clinical Perfusion Service by Region (2019-2024)
8.2 Middle East & Africa Clinical Perfusion Service 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Clinical Perfusion Service 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Clinical Perfusion Service 麻豆原创 Forecast
10.1 Global Clinical Perfusion Service Forecast by Region (2025-2030)
10.1.1 Global Clinical Perfusion Service Forecast by Region (2025-2030)
10.1.2 Americas Clinical Perfusion Service Forecast
10.1.3 APAC Clinical Perfusion Service Forecast
10.1.4 Europe Clinical Perfusion Service Forecast
10.1.5 Middle East & Africa Clinical Perfusion Service Forecast
10.2 Americas Clinical Perfusion Service Forecast by Country (2025-2030)
10.2.1 United States 麻豆原创 Clinical Perfusion Service Forecast
10.2.2 Canada 麻豆原创 Clinical Perfusion Service Forecast
10.2.3 Mexico 麻豆原创 Clinical Perfusion Service Forecast
10.2.4 Brazil 麻豆原创 Clinical Perfusion Service Forecast
10.3 APAC Clinical Perfusion Service Forecast by Region (2025-2030)
10.3.1 China Clinical Perfusion Service 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Clinical Perfusion Service Forecast
10.3.3 Korea 麻豆原创 Clinical Perfusion Service Forecast
10.3.4 Southeast Asia 麻豆原创 Clinical Perfusion Service Forecast
10.3.5 India 麻豆原创 Clinical Perfusion Service Forecast
10.3.6 Australia 麻豆原创 Clinical Perfusion Service Forecast
10.4 Europe Clinical Perfusion Service Forecast by Country (2025-2030)
10.4.1 Germany 麻豆原创 Clinical Perfusion Service Forecast
10.4.2 France 麻豆原创 Clinical Perfusion Service Forecast
10.4.3 UK 麻豆原创 Clinical Perfusion Service Forecast
10.4.4 Italy 麻豆原创 Clinical Perfusion Service Forecast
10.4.5 Russia 麻豆原创 Clinical Perfusion Service Forecast
10.5 Middle East & Africa Clinical Perfusion Service Forecast by Region (2025-2030)
10.5.1 Egypt 麻豆原创 Clinical Perfusion Service Forecast
10.5.2 South Africa 麻豆原创 Clinical Perfusion Service Forecast
10.5.3 Israel 麻豆原创 Clinical Perfusion Service Forecast
10.5.4 Turkey 麻豆原创 Clinical Perfusion Service Forecast
10.6 Global Clinical Perfusion Service Forecast by Type (2025-2030)
10.7 Global Clinical Perfusion Service Forecast by Application (2025-2030)
10.7.1 GCC Countries 麻豆原创 Clinical Perfusion Service Forecast
11 Key Players Analysis
11.1 Perfusion Life
11.1.1 Perfusion Life Company Information
11.1.2 Perfusion Life Clinical Perfusion Service Product Offered
11.1.3 Perfusion Life Clinical Perfusion Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 Perfusion Life Main Business Overview
11.1.5 Perfusion Life Latest Developments
11.2 Keystone
11.2.1 Keystone Company Information
11.2.2 Keystone Clinical Perfusion Service Product Offered
11.2.3 Keystone Clinical Perfusion Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Keystone Main Business Overview
11.2.5 Keystone Latest Developments
11.3 Perfusion Solution Inc
11.3.1 Perfusion Solution Inc Company Information
11.3.2 Perfusion Solution Inc Clinical Perfusion Service Product Offered
11.3.3 Perfusion Solution Inc Clinical Perfusion Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Perfusion Solution Inc Main Business Overview
11.3.5 Perfusion Solution Inc Latest Developments
11.4 EPS
11.4.1 EPS Company Information
11.4.2 EPS Clinical Perfusion Service Product Offered
11.4.3 EPS Clinical Perfusion Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 EPS Main Business Overview
11.4.5 EPS Latest Developments
11.5 Comprehensive Care Services
11.5.1 Comprehensive Care Services Company Information
11.5.2 Comprehensive Care Services Clinical Perfusion Service Product Offered
11.5.3 Comprehensive Care Services Clinical Perfusion Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Comprehensive Care Services Main Business Overview
11.5.5 Comprehensive Care Services Latest Developments
11.6 SpecialtyCare
11.6.1 SpecialtyCare Company Information
11.6.2 SpecialtyCare Clinical Perfusion Service Product Offered
11.6.3 SpecialtyCare Clinical Perfusion Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 SpecialtyCare Main Business Overview
11.6.5 SpecialtyCare Latest Developments
11.7 ECCare
11.7.1 ECCare Company Information
11.7.2 ECCare Clinical Perfusion Service Product Offered
11.7.3 ECCare Clinical Perfusion Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 ECCare Main Business Overview
11.7.5 ECCare Latest Developments
11.8 Perfusion Partners
11.8.1 Perfusion Partners Company Information
11.8.2 Perfusion Partners Clinical Perfusion Service Product Offered
11.8.3 Perfusion Partners Clinical Perfusion Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Perfusion Partners Main Business Overview
11.8.5 Perfusion Partners Latest Developments
11.9 Epic Cardiovascular Services
11.9.1 Epic Cardiovascular Services Company Information
11.9.2 Epic Cardiovascular Services Clinical Perfusion Service Product Offered
11.9.3 Epic Cardiovascular Services Clinical Perfusion Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Epic Cardiovascular Services Main Business Overview
11.9.5 Epic Cardiovascular Services Latest Developments
11.10 Procirca
11.10.1 Procirca Company Information
11.10.2 Procirca Clinical Perfusion Service Product Offered
11.10.3 Procirca Clinical Perfusion Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 Procirca Main Business Overview
11.10.5 Procirca Latest Developments
11.11 Cambridge Perfusion
11.11.1 Cambridge Perfusion Company Information
11.11.2 Cambridge Perfusion Clinical Perfusion Service Product Offered
11.11.3 Cambridge Perfusion Clinical Perfusion Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 Cambridge Perfusion Main Business Overview
11.11.5 Cambridge Perfusion Latest Developments
11.12 Manchester Perfusion Practce
11.12.1 Manchester Perfusion Practce Company Information
11.12.2 Manchester Perfusion Practce Clinical Perfusion Service Product Offered
11.12.3 Manchester Perfusion Practce Clinical Perfusion Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 Manchester Perfusion Practce Main Business Overview
11.12.5 Manchester Perfusion Practce Latest Developments
11.13 Heartbeat Perfusion Solutions
11.13.1 Heartbeat Perfusion Solutions Company Information
11.13.2 Heartbeat Perfusion Solutions Clinical Perfusion Service Product Offered
11.13.3 Heartbeat Perfusion Solutions Clinical Perfusion Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 Heartbeat Perfusion Solutions Main Business Overview
11.13.5 Heartbeat Perfusion Solutions Latest Developments
11.14 XVIVO
11.14.1 XVIVO Company Information
11.14.2 XVIVO Clinical Perfusion Service Product Offered
11.14.3 XVIVO Clinical Perfusion Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.14.4 XVIVO Main Business Overview
11.14.5 XVIVO Latest Developments
11.15 Life Systems
11.15.1 Life Systems Company Information
11.15.2 Life Systems Clinical Perfusion Service Product Offered
11.15.3 Life Systems Clinical Perfusion Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.15.4 Life Systems Main Business Overview
11.15.5 Life Systems Latest Developments
11.16 Adendorff
11.16.1 Adendorff Company Information
11.16.2 Adendorff Clinical Perfusion Service Product Offered
11.16.3 Adendorff Clinical Perfusion Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.16.4 Adendorff Main Business Overview
11.16.5 Adendorff Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.